Turtle Cameron Insider Trading Activity
Turtle Cameron has been net-selling over the last 12 months with 0 purchases and 19 sales across 1 company.
SYRE is the most-traded position with 19 trades. The largest single transaction was a sale of SYRE for $651K on Nov 3, 2025.
Performance Scorecard
Forward stock performance after each transaction by Turtle Cameron. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -13.8% | 26% | 19 |
| 90 days | — | -64.9% | 0% | 13 |
| 120 days | — | -99.5% | 0% | 11 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersSYRE · Spyre Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Turtle Cameron bought and sold SYRE.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 1, 2026 | SYRE | Sell | 5,300 | $69.54 | $369K | −0.8% | CEO | |
May 1, 2026 | SYRE | Sell | 3,600 | $70.77 | $255K | −0.6% | CEO | |
May 1, 2026 | SYRE | Sell | 1,000 | $71.76 | $72K | −0.2% | CEO | |
May 1, 2026 | SYRE | Sell | 3,100 | $73.14 | $227K | −0.5% | CEO | |
May 1, 2026 | SYRE | Sell | 1,700 | $74.23 | $126K | −0.3% | CEO | |
May 1, 2026 | SYRE | Sell | 300 | $74.96 | $22K | −0.0% | CEO | |
Apr 1, 2026 | SYRE | Sell | 12,344 | $49.20 | $607K | −1.9% | CEO | |
Apr 1, 2026 | SYRE | Sell | 2,656 | $49.92 | $133K | −0.4% | CEO | |
Mar 2, 2026 | SYRE | Sell | 5,900 | $41.73 | $246K | −0.9% | CEO | |
Mar 2, 2026 | SYRE | Sell | 9,100 | $42.49 | $387K | −1.4% | CEO | |
Feb 2, 2026 | SYRE | Sell | 957 | $31.82 | $30K | −0.1% | CEO | |
Feb 2, 2026 | SYRE | Sell | 14,043 | $32.87 | $462K | −2.1% | CEO | |
Jan 2, 2026 | SYRE | Sell | 12,709 | $30.47 | $387K | −1.9% | CEO | |
Jan 2, 2026 | SYRE | Sell | 2,191 | $31.79 | $70K | −0.3% | CEO | |
Jan 2, 2026 | SYRE | Sell | 100 | $32.39 | $3K | −0.0% | CEO | |
Dec 1, 2025 | SYRE | Sell | 10,995 | $28.73 | $316K | −1.6% | CEO | |
Dec 1, 2025 | SYRE | Sell | 4,005 | $29.83 | $119K | −0.6% | CEO | |
Nov 3, 2025 | SYRE | Sell | 28,155 | $23.13 | $651K | −3.8% | CEO | |
Nov 3, 2025 | SYRE | Sell | 16,845 | $23.66 | $399K | −2.3% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | 19 | $4.9M |
Other insiders at Spyre Therapeutics, Inc.
3 other tracked filers at SYRE.